DD
60
4
RIG
58
4
DRI
48
3
GM
68
3
AZO
48
2
SHW
65
7
ADI
47
2
BSX
70
2
MAS
56
5
PVH
57
5
NSC
57
7
MMC
60
6
ICE
62
3
ACN
49
2
NWL
50
6
RL
68
3
HAL
60
2
CFG
64
2
LH
45
3
XEL
69
2
DD
60
4
RIG
58
4
DRI
48
3
GM
68
3
AZO
48
2
SHW
65
7
ADI
47
2
BSX
70
2
MAS
56
5
PVH
57
5
NSC
57
7
MMC
60
6
ICE
62
3
ACN
49
2
NWL
50
6
RL
68
3
HAL
60
2
CFG
64
2
LH
45
3
XEL
69
2
Financhill
Back

Nxera Pharma Vs. Target Industry Stock Comparison

Sell
49

SOLTF
Nxera Pharma

Last Price:
8.05
Seasonality Move:
14.44%
Sell
20

TGT
Target

Last Price:
121.59
Seasonality Move:
4.08%
Sell
49
Nxera Pharma (SOLTF) is a Sell

Is Nxera Pharma a Buy, Sell or Hold?

  • The current Nxera Pharma [SOLTF] share price is $8.05. The Score for SOLTF is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • SOLTF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
20
Target (TGT) is a Sell

Is Target a Buy, Sell or Hold?

  • The current Target [TGT] share price is $121.59. The Score for TGT is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • TGT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

SOLTF Stock Price Chart

What is Nxera Pharma's stock price today?

  • The Nxera Pharma share price today is $8.05
    The current trend is relatively stagnant and SOLTF is experiencing slight buying pressure.

TGT Stock Price Chart

What is Target's stock price today?

  • The Target share price today is $121.59
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TGT is experiencing slight selling pressure.

SOLTF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 52.73 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.32 - 8.02) Buy
Bollinger Bands (100): (8.01 - 10.11) Sell

TGT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.85 Sell
Relative Strength Index (14 RSI): 23.91 Sell
Chaikin Money Flow: -8404826 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (140.56 - 157.62) Sell
Bollinger Bands (100): (142.35 - 156.95) Sell

SOLTF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.05 Sell
20-day SMA: 7.73 Buy
50-day SMA: 8.28 Sell
200-day SMA: 9.4 Sell
8-day EMA: 8.01 Buy
20-day EMA: 7.94 Buy
50-day EMA: 8.26 Sell
200-day EMA: 9.39 Sell

TGT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 146.51 Sell
20-day SMA: 148.61 Sell
50-day SMA: 151.64 Sell
200-day SMA: 153.85 Sell
8-day EMA: 141.24 Sell
20-day EMA: 147.16 Sell
50-day EMA: 149.8 Sell
200-day EMA: 149.63 Sell

Nxera Pharma Earnings Growth & SOLTF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Target Earnings Growth & TGT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, an increase next quarter of $0.33 per share, an increase this year of $2.81 per share, and an increase next year of $0.38 per share.

Nxera Pharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Target Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):